Efficiency of two available kits for amplification of three EGFR SNPs in patients with NSCLC: 181946 G/A (rs2293347), -191 C/A (rs712830) and -216G/T (rs712829) with GC-rich regions
https://doi.org/10.20538/1682-0363-2025-1-134-140
Abstract
Aim. To conduct a comparative analysis of two available kits that contain all necessary reagents and additives in a single reaction mixture, including 100 mM Tris-НCl, 100 mM KCL, 4 mM MgSO4, 0.2% of Tween 20, for the amplification of the three most common EGFR (epidermal growth factor receptor) gene polymorphisms in patients with non-small cell lung cancer (NSCLC): 181946 G/A (rs2293347), -191 C/A (rs712830) and -216G/T (rs712829).
Materials and methods. The protocol for genotyping 181946C>T, 191C>A and -216G/T was refined according to previously reported data. Polymerase chain reaction (PCR) products measuring 197 bp were detected using electrophoresis in a 2% agarose gel, followed by staining with ethidium bromide.
Results. The Biomaster HS Taq-PCR Color 2× and Biomaster LR HS PCR 2× reagent kits were effective for amplification of 181946 G/A polymorphism located in the intron of the EGFR gene. Additionally, polymorphisms -191 C/A (rs712829) and -216G/T (rs712829), located in the promoter region and containing a high GC content, were successfully amplified using the Biomaster LR HS PCR 2× kit.
Conclusion. The present study shows that the Biomaster HS Taq-PCR Color 2× and Biomaster LR HS PCR 2× reagent kits are effective for amplification of 181946 G/A polymorphism located in the intron of the EGFR gene. Furthermore, the EGFR SNP -191 C/A, located in the promoter region with a high GC content, was successfully amplified using the Biomaster LR HS PCR 2× reagent kit.
About the Authors
V. JurišićSerbia
69, Svetozar Markovic Str., Kragujevac, 34000
Competing Interests:
The authors declare the absence of obvious or potential conflicts of interest related to the publication of this article.
J. Obradović
Serbia
12, Radoja Domanovicha Str., Kragujevac, 34000
Competing Interests:
The authors declare the absence of obvious or potential conflicts of interest related to the publication of this article.
S. Pavlović
Serbia
1, Student Ave., Belgrade, 11000
Competing Interests:
The authors declare the absence of obvious or potential conflicts of interest related to the publication of this article.
N. Tošić
Serbia
1, Student Ave., Belgrade, 11000
Competing Interests:
The authors declare the absence of obvious or potential conflicts of interest related to the publication of this article.
L. F. Gulaeva
Russian Federation
52, Krasny Av., Novosibirsk, 630091
Competing Interests:
The authors declare the absence of obvious or potential conflicts of interest related to the publication of this article.
E. S. Gershtein
Russian Federation
24, Kashirskoye highway, Moscow, 115522
Competing Interests:
The authors declare the absence of obvious or potential conflicts of interest related to the publication of this article.
N. E. Kushlinskii
Russian Federation
24, Kashirskoye highway, Moscow, 115522
Competing Interests:
The authors declare the absence of obvious or potential conflicts of interest related to the publication of this article.
References
1. Liu W., Innocenti F., Wu M.H., Desai A.A., Dolan M.E., Cook E.H. et al. A functional common polymorphism in a Sp1 recognition site of the epidermal growth factor receptor gene promoter. Cancer Res. 2005;65(1):46–53. PMID: 15665278.
2. Nomura M., Shigematsu H., Li L., Suzuki M., Takahashi T., Estess P. et al. Polymorphisms, mutations, and amplification of the egfr gene in non-small cell lung cancers. PLoS Med. 2007;4(4):e125. DOI: 10.1371/journal.pmed.0040125.
3. Obradović J., Djordjević N., Tošić N., Mrdjanović J., Stanković B., Stanić J. et al. Frequencies of EGFR single nucleotide polymorphisms in non-small cell lung cancer patients and healthy individuals in the Republic of Serbia: a preliminary study. Tumor Biol. 2016;37(8):10479–10486. DOI: 10.1007/s13277-016-4930-4.
4. Ma F., Sun T., Shi Y., Yu D., Tan W., Yang M. et al. Polymorphisms of EGFR predict clinical outcome in advanced non-small-cell lung cancer patients treated with gefitinib. Lung Cancer. 2009;66(1):114–119. DOI: 10.1016/j.lungcan.2008.12.025.
5. Obradovic J., Jurisic V., Tosic N., Mrdjanovic J., Perin B., Pavlovic S. et al. Optimization of PCR conditions for amplification of GC-Rich EGFR promoter sequence. J. Clin. Lab. Anal. 2013;27(6):487–493. DOI: 10.1002/jcla.21632.
6. Hubé F., Reverdiau P., Iochmann S., Gruel Y. Improved PCR method for amplification of GC-rich DNA sequences. Mol. Biotechnol. 2005;31(1):81–84. DOI: 10.1385/MB:31:1:081.
7. Jensen M.A., Fukushima M., Davis R.W. DMSO and betaine greatly improve amplification of GC-rich constructs in de novo synthesis. PLoS One. 2010;5(6):e11024. DOI: 10.1371/journal.pone.0011024.
8. Strien J., Sanft J., Mall G. Enhancement of PCR Amplification of moderate GC-containing and highly GC-rich DNA Sequences. Mol. Biotechnol. 2013;54(3):1048–1054. DOI: 10.1007/s12033-013-9660-x.
9. Jurišić V., Obradović J., Tošić N., Pavlović S., Kulić M., Djordjević N. Effects of DMSO, glycerol, betaine and their combinations in detecting single nucleotide polymorphisms of epidermal growth factor receptor (EGFR) gene promoter sequence in non-small-cell lung cancer (NSCLC) patients. J. Pharm. Biomed. Anal. 2016;128:275–279. DOI: 10.1016/j.jpba.2016.05.010.
10. Lorenz T.C. Polymerase chain reaction: basic protocol plus troubleshooting and optimization strategies. J. Vis. Exp. 2012;(63):e3998. DOI: 10.3791/3998.
11. Sahdev S., Saini S., Tiwari P., Saxena S., Singh Saini K. Amplification of GC-rich genes by following a combination strategy of primer design, enhancers and modified PCR cycle conditions. Mol. Cell Probes. 2007;21(4):303–307. DOI: 10.1016/j.mcp.2007.03.004.
12. Naz S., Fatima A. Amplification of GC-rich DNA for high-throughput family based genetic studies. Mol. Biotechnol. 2013;53(3):345–350. DOI: 10.1007/s12033-012-9559-y.
13. Wei M., Deng J., Feng K., Yu B., Chen Y. Universal method facilitating the amplification of extremely GC-rich DNA fragments from genomic DNA. Anal. Chem. 2010;82(14):6303–6307. DOI: 10.1021/ac100797t.
14. Bachmann B., Luke W., Hunsmann G. Improvement of PCR amplified DNA sequencing with the aid of detergents. Nucleic Acids Res. 1990;18(5):1309. DOI: 10.1093/nar/18.5.1309.
Review
For citations:
Jurišić V., Obradović J., Pavlović S., Tošić N., Gulaeva L.F., Gershtein E.S., Kushlinskii N.E. Efficiency of two available kits for amplification of three EGFR SNPs in patients with NSCLC: 181946 G/A (rs2293347), -191 C/A (rs712830) and -216G/T (rs712829) with GC-rich regions. Bulletin of Siberian Medicine. 2025;24(1):134-140. https://doi.org/10.20538/1682-0363-2025-1-134-140